GMP-Bios-ab-356 | Pre-Made Mosunetuzumab biosimilar, Bispecific mAb, Anti-CD3E;MS4A1/CD20 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Mosunetuzumab | | CD3E;MS4A1/CD20 | Bispecific mAb |  |
GMP-Bios-INN-790 | Pre-Made Dafsolimab Setaritox Biosimilar, Whole Mab Adc, Anti-Cd3E Antibody: Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic antibody Drug Conjugate | dafsolimab setaritox | | CD3E | Whole mAb ADC |  |
GMP-Bios-ab-546 | Pre-Made Talquetamab biosimilar, Bispecific mAb, Anti-GPRC5D;CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Talquetamab | | GPRC5D;CD3E | Bispecific mAb |  |
GMP-Bios-ab-622 | Pre-Made Visilizumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Visilizumab | | CD3E | Whole mAb |  |
GMP-Bios-ab-386 | Pre-Made Obrindatamab biosimilar, Bispecific scFv with Domain Crossover, Anti-CD276;CD3E Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2;T3E/TCRE/IMD18 therapeutic antibody | Obrindatamab | | CD276;CD3E | Bispecific scFv with Domain Crossover |  |
GMP-Bios-ab-104 | Pre-Made Cibisatamab biosimilar, Bispecific mAb with Domain Crossover: Anti-CEACAM5;CD3E therapeutic antibody | Cibisatamab | | CEACAM5;CD3E | Bispecific mAb with Domain Crossover |  |
GMP-Bios-ab-391 | Pre-Made Odronextamab biosimilar, Bispecific mAb, Anti-MS4A1/CD20;CD3E Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18 therapeutic antibody | Odronextamab | | MS4A1/CD20;CD3E | Bispecific mAb |  |
GMP-Bios-ab-500 | Pre-Made Runimotamab biosimilar, Bispecific mAb, Anti-ERBB2/HER2;CD3E Antibody: Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;T3E/TCRE/IMD18 therapeutic antibody | Runimotamab | | ERBB2/HER2;CD3E | Bispecific mAb |  |
GMP-Bios-ab-248 | Pre-Made Glofitamab biosimilar, Bispecific mAb with Domain Crossover, Anti-CD3E;MS4A1/CD20 antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7therapeutic antibody | Glofitamab | | CD3E;MS4A1/CD20 | Bispecific mAb with Domain Crossover |  |
GMP-Bios-ab-705 | Pre-Made Ubamatamab biosimilar, Whole mAb, Anti-MUC16;CD3E Antibody: Anti-CA125;T3E/TCRE/IMD18 therapeutic antibody | Ubamatamab | | MUC16;CD3E | Bispecific Whole mAb |  |
GMP-Bios-ab-197 | Pre-Made Etevritamab biosimilar, Bispecific scFv, Anti-EGFR;CD3E Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;T3E/TCRE/IMD18 therapeutic antibody | Etevritamab | | EGFR;CD3E | Bispecific scFv |  |
GMP-Bios-ab-663 | Pre-Made Elranatamab biosimilar, Whole mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Elranatamab | | TNFRSF17;CD3E | Bispecific Whole mAb |  |
GMP-Bios-ab-708 | Pre-Made Vepsitamab biosimilar, Whole mAb, Anti-MUC17;CD3E Antibody: Anti-MUC-17/MUC-3/MUC3;T3E/TCRE/IMD18 therapeutic antibody | Vepsitamab | | MUC17;CD3E | Bispecific scFv-scFv-scFc |  |
GMP-Bios-ab-446 | Pre-Made Plamotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-MS4A1/CD20;CD3E Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18 therapeutic antibody | Plamotamab | | MS4A1/CD20;CD3E | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-176 | Pre-Made Emerfetamab biosimilar, Bispecific scFv, Anti-CD33;CD3E Antibody: Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18 therapeutic antibody | Emerfetamab | | CD33;CD3E | Bispecific scFv |  |
GMP-Bios-ab-414 | Pre-Made Otelixizumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Otelixizumab | | CD3E | Whole mAb |  |
GMP-Bios-ab-562 | Pre-Made Teplizumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Teplizumab | | CD3E | Whole mAb |  |
GMP-Bios-ab-433 | Pre-Made Pavurutamab biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Pavurutamab | | TNFRSF17;CD3E | Bispecific scFv |  |
GMP-Bios-ab-709 | Pre-Made Voxalatamab biosimilar, Whole mAb, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody | Voxalatamab | | FOLH1/GCPII;CD3E | Bispecific Whole mAb |  |
GMP-Bios-ab-570 | Pre-Made Tidutamab biosimilar, Bispecific Mixed mAb and scFv, Anti-SSTR2;CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Tidutamab | | SSTR2;CD3E | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-619 | Pre-Made Vibecotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-IL3RA;CD3E Antibody: Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18 therapeutic antibody | Vibecotamab | | IL3RA;CD3E | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-624 | Pre-Made Vixtimotamab biosimilar, Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody)), Anti-CD3E;CD33 Antibody: Anti-T3E/TCRE/IMD18;p67/SIGLEC3/SIGLEC-3 therapeutic antibody | Vixtimotamab | | CD3E;CD33 | Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody) |  |
GMP-Bios-ab-189 | Pre-Made Envafolimab biosimilar, Single Domain Variable Fragment;H, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PD-L1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1 therapeutic antibody | Epcoritamab | | CD3E;MS4A1/CD20 | Bispecific mAb |  |
GMP-Bios-ab-006 | Pre-Made Acapatamab biosimilar, Bispecific scFv, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody | Acapatamab | | FOLH1/GCPII;CD3E | Bispecific scFv |  |
GMP-Bios-ab-074 | Pre-Made Blinatumomab biosimilar, Bispecific T-Cell Engager, Anti-CD19;CD3E Antibody: Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic antibody | Blinatumomab | | CD19;CD3E | Bispecific T-Cell Engager |  |
GMP-Bios-ab-650 | Pre-Made Zolimomab biosimilar, Whole mAb, Anti-CD5 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Zolimomab | | CD5 | Whole mAb |  |
GMP-Bios-ab-670 | Pre-Made Gresonitamab biosimilar, Whole mAb, Anti-CLDN18;CD3E Antibody: Anti-SFTA5/SFTPJ;T3E/TCRE/IMD18 therapeutic antibody | Gresonitamab | | CLDN18;CD3E | Bispecific scFv-scFv-scFc |  |
GMP-Bios-ab-421 | Pre-Made Pacanalotamab biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Pacanalotamab | | TNFRSF17;CD3E | Bispecific scFv |  |
GMP-Bios-ab-429 | Pre-Made Pasotuxizumab biosimilar, Bispecific scFv, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody | Pasotuxizumab | | FOLH1/GCPII;CD3E | Bispecific scFv |  |
GMP-Bios-ab-130 | Pre-Made Dafsolimab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Dafsolimab | | CD3E | Whole mAb |  |
GMP-Bios-INN-772 | Pre-Made Catumaxomab Biosimilar, Bispecific, Anti-Cd3E; Epcam Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody | catumaxomab | | CD3E;EPCAM | Bispecific |  |
GMP-Bios-INN-921 | Pre-Made Muromonab-Cd3 3Iosimilar, Whole Mab, Anti-Cd3E Antibody: Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic antibody | muromonab-CD3 | | CD3E | Whole mAb |  |
GMP-Bios-ab-360 | Pre-Made Muromonab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Muromonab | | CD3E | Whole mAb |  |
GMP-Bios-ab-218 | Pre-Made Flotetuzumab biosimilar, Bispecific scFv with Crossover, Anti-IL3RA;CD3E Antibody: Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18 therapeutic antibody | Flotetuzumab | | IL3RA;CD3E | Bispecific scFv with Crossover |  |
GMP-Bios-ab-173 | Pre-Made Eluvixtamab biosimilar, Bispecific scFv, Anti-CD33;CD3E Antibody: Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18 therapeutic antibody | Eluvixtamab | | CD33;CD3E | Bispecific scFv |  |
GMP-Bios-ab-552 | Pre-Made Tarlatamab biosimilar, Bispecific scFv, Anti-DLL3;CD3E Antibody: Anti-SCDO1;T3E/TCRE/IMD18 therapeutic antibody | Tarlatamab | | DLL3;CD3E | Bispecific scFv |  |
GMP-Bios-ab-563 | Pre-Made Tepoditamab biosimilar, Bispecific mAb, Anti-CLEC12A/CD371;CD3E Antibody: Anti-CLL-1/CLL1/DCAL-2/MICL;T3E/TCRE/IMD18 therapeutic antibody | Tepoditamab | | CLEC12A/CD371;CD3E | Bispecific mAb |  |
GMP-Bios-ab-380 | Pre-Made Nivatrotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-GD2;CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Nivatrotamab | | GD2;CD3E | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-018 | Pre-Made Alnuctamab biosimilar, Bispecific mAb with Domain Crossover, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Alnuctamab | | TNFRSF17;CD3E | Bispecific mAb with Domain Crossover |  |
GMP-Bios-ab-528 | Pre-Made Solitomab biosimilar, Bispecific scFv, Anti-EPCAM;CD3E Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1;T3E/TCRE/IMD18 therapeutic antibody | Solitomab | | EPCAM;CD3E | Bispecific scFv |  |
GMP-Bios-INN-845 | Pre-Made Ertumaxomab Biosimilar, Bispecific, Anti-Cd3E;Erbb2 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | ertumaxomab | | CD3E;ERBB2 | Bispecific |  |
GMP-Bios-ab-557 | Pre-Made Teclistamab biosimilar, Bispecific mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Teclistamab | | TNFRSF17;CD3E | Bispecific mAb |  |
GMP-Bios-ab-220 | Pre-Made Foralumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Foralumab | | CD3E | Whole mAb |  |
GMP-Bios-ab-555 | Pre-Made Tebentafusp biosimilar, scFv Fusion, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Tebentafusp | | CD3E | scFv Fusion |  |
GMP-Bios-ab-161 | Pre-Made Duvortuxizumab biosimilar, Bispecific scFv with Crossover, Anti-CD19;CD3E antibody: Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic antibody | Duvortuxizumab | | CD19;CD3E | Bispecific scFv with Crossover |  |